Results 181 to 190 of about 306,427 (234)

ECG markers of left ventricular hypertrophy indicate response to mavacamten in hypertrophic obstructive cardiomyopathy. [PDF]

open access: yesOpen Heart
Buehning F   +9 more
europepmc   +1 more source

Surgical Myectomy with Anterior Mitral Leaflet Extension Versus Isolated Myectomy in Patients with Hypertrophic Obstructive Cardiomyopathy. [PDF]

open access: yesThorac Cardiovasc Surg
Heeringa TJP   +14 more
europepmc   +1 more source

Correction: Safety and Effectiveness of Mavacamten Use in Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-Analysis. [PDF]

open access: yesCureus
Alharbi TY   +8 more
europepmc   +1 more source

Obstructive Hypertrophic Cardiomyopathy

Progress in Cardiovascular Nursing, 2004
Hypertrophic cardiomyopathy (HCM) is a primary disease of cardiac muscle characterized by a thickening of the left ventricular wall and often predominantly affecting the interventricular septum. This paper presents a case study of a 53‐year‐old female with a dynamic and obstructive form of HCM. The study includes a case presentation, clinical findings,
Melissa A, Graham-Cryan   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy